Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
Thrombotic microangiopathy is a form of antibody-mediated rejection (ABMR): it is the main complication of ABO-incompatible (ABOi) kidney transplantation (KT). Herein, we report on two cases of ABMR with biological and histological features of thrombotic microangiopathy (TMA) that were treated by ec...
Saved in:
Main Authors: | Luca Lanfranco, Melanie Joly, Arnaud Del Bello, Laure Esposito, Noelle Cognard, Peggy Perrin, Bruno Moulin, Nassim Kamar, Sophie Caillard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2017/3197042 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation
by: Ömür Gökmen Sevindik, et al.
Published: (2015-01-01) -
Leptospirosis Presenting with Features of Thrombotic Microangiopathy
by: Chaudhry Adeel Ebad, et al.
Published: (2020-01-01) -
Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ER
by: Kamia Thakur, et al.
Published: (2017-01-01) -
Pulmonary Tumor Thrombotic Microangiopathy from Metastatic Prostate Carcinoma
by: Dhruv Nayyar, et al.
Published: (2015-01-01) -
Severe Acral Necrosis Complicating Thrombotic Microangiopathy in Two Toddlers
by: H. Nassih, et al.
Published: (2020-01-01)